- Received March 11, 2021
- Accepted August 09, 2021
- Publication November 25, 2021
- Visibility 37 Views
- Downloads 0 Downloads
- DOI 10.18231/j.ijpo.2021.100
-
CrossMark
- Citation
Histomorphological spectrum of intracranial space occupying lesions: Experience at tertiary care centre
- Author Details:
-
Devika S Kinkhede
-
Saroj A Meshram *
-
Sanjay N Parate
-
Dinkar T Kumbhalkar
-
Shilpa P Tathe
-
Archana A Randale
Introduction
An “Intra-cranial space occupying lesion” (ICSOL) is defined as mass lesion in the cranial cavity with a diverse etiology like benign or malignant neoplasm, inflammatory or parasitic lesion, haematoma or arterio-venous malformation.[1]
ICSOLs can be caused due to cysts, cerebrovascular disorders, infections, tumours.
The most common cause of ICSOL is neoplastic followed by non-neoplastic lesions.
CNS (central nervous system) neoplasms represent a unique, heterogenous population of neoplasms constituting 1.9% of all malignant tumors in India.
Tumours of CNS account for 2% of all cancers in adults and 20% in childhood.[2]
Moreover, the CNS tumours that predominate in adults differ from those seen in children, in terms of frequency, histological type and location.[3]
ICSOLs can clinically present as headache, vomiting, seizures, behavioural problems, focal deficits and visual difficulties.[4]
Radiological assessment helps in diagnosing the presence of an ICSOL, its location and its nature- whether benign or malignant, changes in the lesion like necrosis, intratumoural haemorrhage, surrounding edema and mass effect caused by ICSOL.[5]
But radiological imaging cannot give exact diagnosis of the ICSOL.
For definitive diagnosis, histopathology remains the gold standard for diagnosis and grading of tumours, based on which treatment protocol of patient is determined.
In developing countries like India due to lack of complete registration of newly diagnosed cases, exact tumour burden goes unnoticed and is underestimated. Hospital based data, therefore, forms the basis for estimating the disease load.[6]
The present study attempts to provide information about the histopathological spectrum of ICSOL at a tertiary care centre/ hospital in order to give accurate pretherapeutic histomorphological diagnosis helping to facilitate better therapeutic results.
Materials and Methods
This prospective and descriptive type of study of two years duration was carried out from November 2017 to October 2019 in Govt. Medical College and Superspeciality Hospital, Nagpur in the Department of Pathology. A total of 300 samples were received from Department of Neurosurgery.
Inclusion criteria
All biopsy/ resected specimen of ICSOLs.
Presence of ICSOL in patients was confirmed on radiological imaging.
Exclusion criteria
Haematoma and arteriovenous malformations.
Bony lesions of skull.
Spinal cord lesions.
Detailed collection of clinical data was done in all patients regarding age, sex, clinical symptoms and radiological findings. Informed consent was obtained from patients.
The samples were received in 10% formalin in labelled containers which comprised of biopsies or resected specimens.
The samples received were usually in multiple tissue pieces, mostly grey white to grey black in colour which were then subjected to routine histopathological processing. Slides prepared were stained with hematoxylin and eosin stain. Special stains were done wherever necessary.
Histomorphologically, ICSOLs were classified as neoplastic and non neoplastic lesions. The tumours were classified according to the WHO classification of tumours of central nervous system.7
Statistical analysis was performed using Microsoft Excel software.
The study was approved by institutional ethical committee.
Results
A total of 300 resected tumours/ biopsies were studied. Radiological and histomorphological diagnosis was available in all 300 cases.
The most common age group affected was 31-40 years (23.68%) followed by 41-50 years of age group (20.33%). The average age was 36.33 years.
55 cases belonged to the paediatric age group.
Out of 300 cases, 169 (56%) were male and 131 (44%) were female. The male to female ratio was 1.3:1.
In males, 41 cases were seen in the age group 31-40 years followed by 35 cases in 41-50 years of age.
Similarly, in females, highest number of cases (30 cases) were seen in 31-40 years of age group followed by 26 cases in 41-50 years of age and 24 cases in 21-30 years of age. ([Figure 1])

The most common clinical presentation in patients was headache (78%) followed by vomiting (32%), loss of consciousness (22%), convulsions (17%) and diminution of vision (17%).
220 cases (73%) were located supratentorially and 80 cases (27%) infratentorially.
The distribution of ICSOLs in each compartment is given in [Table 1].
S. No |
Location |
No of cases |
% |
1 |
Supratentorial |
220 |
73 |
Frontal lobe |
48 |
16 |
|
Temporal lobe |
23 |
7.7 |
|
Parietal lobe |
37 |
12.3 |
|
Occipital lobe |
4 |
1.3 |
|
Multiple lobes |
59 |
19.7 |
|
Suprasellar & sellar region |
34 |
11.3 |
|
Corpus callosum |
3 |
1 |
|
Lateral ventricles |
7 |
2.3 |
|
Pineal region |
1 |
0.3 |
|
Thalamus |
2 |
0.7 |
|
Parasagittal region |
2 |
0.7 |
|
2 |
Infratentorial |
80 |
27 |
CP angle |
32 |
10.7 |
|
Cerebellum |
35 |
11.7 |
|
Fourth ventricle |
12 |
4 |
|
Midbrain |
1 |
0.3 |
|
Total |
300 |
100 |
Out of 300 ICSOLs, 261 cases (87%) were neoplastic in nature and 39 cases (13%) were non neoplastic.
Out of 261 neoplastic ICSOLs, 250 cases (96%) were of primary tumours and 11 cases (4%) were of metastatic deposits. Amongst primary tumours, 124 cases (48%) were of glioma followed by 51 cases (20%) of meningioma and 24 cases (9%) of schwannomas. Distribution of neoplastic ICSOLs is given in [Table 2].
S. No |
Histomorphological subtypes |
No cases |
% |
1 |
Glioma |
124 |
48% |
2 |
Meningioma |
51 |
20% |
3 |
Schwannoma |
24 |
9% |
4 |
Pituitary adenoma |
18 |
7% |
5 |
Craniopharyngioma |
12 |
5% |
6 |
Hemangioblastoma |
6 |
2% |
7 |
Medulloblastoma |
4 |
1.1% |
8 |
Choroid plexus papilloma |
3 |
1% |
9 |
Central neurocytoma |
2 |
0.7 |
10 |
Cavernous angioma |
2 |
0.7 |
11 |
Germ cell tumour |
2 |
0.7 |
12 |
Pineoblastoma |
1 |
0.4 |
13 |
Non Hodgkin’s lymphoma |
1 |
0.4 |
14 |
Metastatic tumour |
11 |
4 |
Total |
261 |
100 |
In gliomas, the most common type was glioblastoma (51 cases, 41.1%) followed by astrocytomas (22 cases, 18%). Out of 51 cases of glioblastomas, 35 cases (68.6%) belonged to age group 31-60 years. ([Figure 2])

Amongst meningiomas, the most common subtype was meningothelial meningioma (25 cases, 49.03%). ([Table 3])
S. No |
Histopathological diagnosis |
No of cases |
% |
1 |
Meningothelial |
25 |
49.03 |
2 |
Transitional |
6 |
11.76 |
3 |
Angiomatous |
4 |
7.84 |
4 |
Fibrous (Fibroblastic) |
3 |
5.88 |
5 |
Clear cell |
2 |
3.92 |
6 |
Psammomatous |
2 |
3.92 |
7 |
Chordoid |
1 |
1.96 |
8 |
Atypical |
8 |
15.69 |
Total |
51 |
100 |
Female preponderance of 29 cases (57%) was noted in meningiomas.
Tumours were graded according to WHO criteria.[7]
Out of 250 primary tumours, pituitary adenomas, lymphomas, cavernous angiomas and germ cell tumours were not assigned grades.
Grade I tumours were in majority (41%) followed by grade II and IV tumours which were 24% each and grade III tumours (11%). ([Figure 3])

Out of 39 cases of non neoplastic ICSOL the most common was abscess (16 cases, 41.02%) closely followed by epidermoid cyst (15 cases, 38.46%). Other non neoplastic lCSOLs encountered were tuberculomas (12.82%), hydatid cyst (5.14%) and Rathke’s cleft cyst (2.56%).
S. No |
Author |
Year |
Gliomas |
Meningiomas |
Schwannomas |
1 |
Butt et al |
2005 |
43% |
25.8% |
12% |
2 |
Kothari et al |
2014 |
40% |
22% |
6% |
3 |
Lakshmi et al |
2015 |
50.7% |
23.6% |
5.5% |
4 |
Dogar et al |
2015 |
46% |
13% |
-- |
5 |
Anadure et al |
2016 |
50% |
12.5% |
14% |
6 |
Adnan et al |
2017 |
35.4% |
22.9% |
8.6% |
7 |
Kaki RR et al |
2017 |
28% |
- |
6% |
8 |
Shihora et al |
2020 |
33.3% |
25.5% |
21.57% |
9 |
Khonglah et al |
2020 |
27.8% |
20.97% |
18.4% |
10 |
Present study |
2019 |
47.5% |
19.5% |
9% |









Discussion
The present study is an attempt to assess the histomorphological spectrum of ICSOLs at a tertiary care centre/ hospital.
The most common age group affected was 31-40 years (23.68%) followed by 41-50 years of age group (20.33%). Studies by Hema et al, Masoodi et al, Dogar et al, Pachori et al, Khonglah et al and Shihora et al also showed maximum cases in the age group 31-40 years.[2], [8], [9], [10], [11], [12]
The male to female ratio was 1.3:1. Our finding was similar to studies by Chawla et al, Nibhoria et al, Rathod et al, Butt et al, Adnan et al, Joshi et al.[4], [6], [13], [14], [15], [16]
The most common clinical presentation was headache (78%). Hema et al, Masoodi et al, Khonglah et al, Rathod et al, Joshi et al, Kaki RR et al and Datta et al also reported similar observation.[2], [8], [11], [13], [16], [17], [18]
Out of total 300 cases, 220 cases (73%) were located supratentorially and 80 cases (27%) infratentorially. These findings were seen to correspond with studies by Jamjoom et al, Masoodi et al, Pachori et al and Kaki RR et al.[1], [8], [10], [17]
In supratentorial compartment, majority (19.7%) of cases showed multiple lobe involvement followed by 48 cases (16%) involving frontal lobe. Masoodi et al and Shashidhar et al reported 21.7% and 30% of multiple lobe involvement respectively in their study.[8], [19] 20.7%, 23%, 10%, 15.5% of ICSOLs were located in frontal lobe in studies by Masoodi et al, Shashidhar et al, Lakshmi et al and Thambi et al respectively.[8], [19], [20], [21] These findings correlated well with our study.
In infratentorial compartment, 35 cases (11.7%) showed involvement of cerebellum followed by 32 cases (10.7%) involving cerebellopontine angle (CP) angle. Suprasellar and sellar region, cerebellum and CP angle showed variable distribution across multiple studies.[8], [12], [19], [20], [21]
Out of 300 cases, 261 cases (87%) were neoplastic in nature and 39 cases (13%) were non neoplastic. Jamjoom et al, Dogar et, Khonglah et al, Butt et al and Adnan et al reported 87%, 89%, 86.13%, 89% and 77.8% of neoplastic ICSOLs and 13%, 11%, 13.86%, 11% and 22.2% of non neoplastic ICSOLs respectively.[1], [9], [11], [14], [15]
250 cases (96%) were of primary tumour and 11 cases (4%) were of metastatic deposits. These findings were in agreement with studies by Hema et al, Nibhoria et al, Khonglah et al, Shihora et al, Butt et al, Joshi et al, Kaki RR et al, Lakshmi et al and Kanthikar et al.[2], [6], [11], [12], [14], [16], [17], [20], [22]
Out of 261 neoplastic ICSOLs, majority belonged to gliomas (48%) followed by meningiomas (20%) and schwannomas (9%). ([Table 4]) Hema et al, Dogar et al, Khonglah et al, Butt et al, Adnan et al, Kaki RR et al, Lakshmi et al and Kothari et al reported 50%, 46%, 27.8%, 43%, 35.4%, 28%, 50.7% and 40% of glial tumours respectively in their studies.[2], [9], [11], [14], [15], [17], [20], [23]
In case of meningiomas our findings were in agreement with studies by Khonglah et al, Shihora et al, Butt et al, Adnan et al, Joshi et al, Datta et al and Kothari et al. [11], [12], [14], [15], [16], [18], [23] Studies by Pachori et al (42.8%) and Kaki RR et al (32%) reported higher percentage of meningiomas.[10], [17]
Studies by Hema et al (14%), Butt et al (12%), Adnan et al (8.6%), Kaki RR et al (6%), Datta et al (6.5%), Lakshmi et al (5.5%) and Kothari et al (6%) showed similar distribution of schwannomas as in present study.[2], [14], [15], [17], [18], [20], [23] A higher percentage of schwannomas was noted in studies by Khonglah et al (18.04%), Shihora et al (21.57%) and Joshi et al (22.6%).[11], [12], [16]
Amongst gliomas, in our study the most common type was glioblastoma (41.1%) followed by astrocytomas (18%). Our findings were concordant with studies by Masoodi et al, Pachori et al, Khonglah et al, Adnan et al, Thambi et al and Kakshapati et al.[8], [10], [11], [15], [21], [24]
68.6% of glioblastomas belonged to age group 31-60 years. Masoodi et al reported that 75% of glioblastomas in age group 31-50 years and Khonglah et al observed a mean age of 42.38 years.[8], [11] Adnan et al too reported most cases of glioblastoma above 40 years.[15]
In present study, the most common histologic subtype amongst meningiomas was meningothelial meningioma represented by 25 cases (49.03%) followed by 8 cases of atypical meningioma (15.69%) and 6 cases of transitional meningioma (11.76%). Other studies showed variable distribution of histomorphological subtypes of meningioma.[2], [6], [11], [12], [19], [24], [25], [26], [27]
Meningiomas showed female predominance of 29 cases (57%). Our findings were concordant with studies by Nibhoria et al, Khonglah et al, Adnan et al, Kakshapati et al and Priscilla et al.[6], [11], [15], [24], [26]
In our study, grade I tumours were in majority (41%) followed by grade II and IV tumours which were 24% each and grade III tumours (11%). Similar findings were also observed in studies by Shihora et al, Kakshapati et al, Jat et al, Priscilla et al and Jaiswal et al.[12], [24], [25], [26], [28]
Out of 300 ICSOLs, the most common non neoplastic ICSOL was abscess (5.3%) closely followed by epidermoid cyst (5%). Jamjoom et al, Hema et al, Shihora et al, and Joshi et al reported 6.6%, 6.5%, 3.07% and 8.3% of abscesses respectively, out of all ICSOLs.[1], [2], [12], [16]
1.54%, 3.1%, 2.27% of epidermoid cysts out of all ICSOLs were observed in studies by Shihora et al, Joshi et al and Sunila et al respectively.[12], [16], [27]
In present study, 55 cases (18.33%) belonged to paediatric age group.
Similar findings were reported by Nibhoria et al – 12.3%, Khonglah et al (23.41%), Butt et al - 18% and Jaiswal et al – 16.2%.[6], [11], [14], [28]
Conclusion
The present study gives a glimpse of histomorphological spectrum of ICSOLs which present with nonspecific and overlapping clinical features.
Radiodiagnostic investigations are helpful adjunct tool to diagnose ICSOL but cannot provide exact diagnosis.
In spite of availability of newer diagnostic techniques such as immunohistochemistry and molecular tests, histopathology remains a gold standard in establishing histomorphological diagnosis and grading of tumours.
In the end, clinical, radiological and histomorphological findings- all three must be taken into account before giving the final diagnosis which can help the clinician in deciding the line of management and improve patient healthcare.
Also developing countries lack a central cancer registry for brain tumours. Hence, such hospital based study attempts to give relative frequency of ICSOLs in a particular region.
Source of Funding
None.
Conflict of Interest
The authors declare no conflict of interest.
References
- ZAB Jamjoom. Pattern of intra-cranial space occupying lesions: experience at King Khalid University Hospital. Ann Saudi Med 1989. [Google Scholar]
- NA Hema, RS Ravindra, AS Karnappa. Morphological Patterns of Intracranial Lesions in a Tertiary Care Hospital in North Karnataka: A Clinicopathological and Immunohistochemical Study. J Clin Diagn Res 2016. [Google Scholar]
- G Aryal. Histopathological pattern of central nervous system tumour: A three year retrospective study. J Pathol Nepal 2011. [Google Scholar]
- N Chawla, SP Kataria, S Malik, N Sharma, S Kumar. Histopathological spectrum of CNS tumours in a tertiary care referral centre-A one year study. Int J Basic Appl Med Sci 2014. [Google Scholar]
- N Jindal, SR Verma, PK Gupta, M Mital. Imaging of Intracranial Space Occupying Lesions: A Prospective Study in A Tertiary Care Centre in Northern India. IOSR J Dent Med Sci 2016. [Google Scholar] [Crossref]
- S Nibhoria, K K Tiwana, R Phutela, A Bajaj, S Chhabra, S Bansal. Histopathological Spectrum of Central Nervous System Tumors: A Single Centre Study of 100 Cases. Int J Sci Stud 2015. [Google Scholar]
- DN Louis, H Ohgaki, OD Wiestler, WK Cavenee. . WHO Classification of tumours of the central nervous system 2007. [Google Scholar]
- T Masoodi, RK Gupta, JP Singh, A Khajuria. Pattern of Central Nervous System Neoplasms: A Study of 106 Cases. JK-Practitioner 2012. [Google Scholar]
- T Dogar, AA Imran, M Hasan, R Jaffar, R Bajwa, ID Qureshi. Space occupying lesions of central nervous system: A radiological and Histopathological Correlation. Biomedica 2015. [Google Scholar]
- G Pachori, NR Dixit, A Sirohi, N Kasliwal, N Jethani, R Sunaria. Clinicopathological Study of CNS Tumors in Ajmer Region. Int J Med Res Prof 2018. [Google Scholar] [Crossref]
- Y Khonglah, D Shangpliang, J Mishra, A Mustafa, A Kakoti, P Phukan. Histological spectrum of central nervous system lesions at a tertiary care center in India. Clin Cancer Investig J 2020. [Google Scholar]
- NV Shihora, HU Patel, SM Patel, PR Ramani, BN Nandasana. A study of histopathological spectrum of central nervous system lesions at a tertiary health care center of South Gujarat, India. Int J Res Med Sci 2020. [Google Scholar]
- V Rathod, A Bhole, M Chauhan, H Ramteke, B Wani. Study of clinicoradiological and clinico-pathological correlation of intracranial space occupying lesion at rural center. Internet J Neurosurg 2009. [Google Scholar]
- ME Butt, SA Khan, NA Chaudrhy, GR Qureshi. Intracranial Space occupying lesions - A morphological analysis. Biomedica 2005. [Google Scholar]
- HA Adnan, UA Kambhoh, S Majeed, AA Imran. Frequency of CNS lesion in a Tertiary Care Hospital - A 5-year study. Biomedica 2017. [Google Scholar]
- H Joshi, S Awasthi, S Dutta, R Bharadwaj. Histopathological spectrum of central nervous system lesions. Trop J Path Micro 2019. [Google Scholar] [Crossref]
- RR Kaki, B Anuradha, BS Rani. Imaging of intracranial space occupying lesions-A prospective study in a tertiary care centre. J Evid Based Med Healthc 2017. [Google Scholar] [Crossref]
- PK Datta, SR Sutradhar, MNAA khan, MZ Hossain, SM Sumon, I Hasan. Clinical pattern of intra cranial space occupying lesion in tertiary level hospital. J Dhaka Med Coll 2019. [Google Scholar] [Crossref]
- SN Shashidhar, T Teerthanath. Clinicopathological study of central nervous system tumours. Indian J Basic Appl Med Res 2017. [Google Scholar]
- K Lakshmi, M Hemalatha, SB Sunkesula, TDS Arasi, LB Rao. Histopathological Study of Spectrum of the Lesions of Central Nervous System in a Tertiary Care Hospital. J Evol Med Dent Sci 2015. [Google Scholar]
- R Thambi, S Kandamuthan, S Sainulabdeen, L Vilasiniamma, TR Abraham, PK Balakrishnan. Histopathological Analysis of Brain Tumours- A Seven Year Study from a Tertiary Care Centre in South India. J Clin Diagn Res 2017. [Google Scholar] [Crossref]
- SN Kanthikar, DB Nikumbh, ND Dravid. Histopathological overview of central nervous system tumours in North Maharashtra, India: a single center study. Indian J Pathol Oncol 2017. [Google Scholar]
- F Kothari, A Shah. Prospective study of intra cranial tumour. SEAJCRR 2014. [Google Scholar]
- T Kakshapati, RB Basnet, B Pant, D Gautam. Histopathological analysis of central nervous system tumors; an observational study. J Pathol Nepal 2018. [Google Scholar]
- KC Jat, SP Vyas, NA Bihari, K Mehra. Central nervous system tumors: a histopathological study. Int J Res Med Sci 2016. [Google Scholar]
- MB Priscilla, PRDG Basina, NC Parankusa, RV Bhaskar. Spectrum of Central Nervous System Tumors - A Four Year Study In A Tertiary Care Center. IOSR-JDMS 2018. [Google Scholar]
- Sunila, BN Kumarguru, TS Vasan, GV Manjunath. Space occupying lesions of central nervous system: A radiological-histopathological correlation study. Indian J Pathol Oncol 2018. [Google Scholar]
- J Jaiswal, AH Shastry, A Ramesh, YT Chickabasaviah, A Arimappamagan, V Santosh. Spectrum of primary intracranial tumors at a tertiary care neurological institute: A hospital-based brain tumor registry. Neurol India 2016. [Google Scholar]